A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAG

Completed · Phase 2

Conditions studied: Ocular Hypertension, Open-Angle Glaucoma

In brief

The objective of this study is to investigate how the intraocular pressure (IOP)-lowering effect of the L-PPDS is altered by adjunctive Xalatan therapy.

Key facts

Study ID

NCT01037036

Run by

Mati Therapeutics Inc.

People needed

15

Starts

2009-12-01

Expected to finish

2010-07-01

Last updated by the study team

2014-01-10

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Over 18 years
• Diagnosed with bilateral Open-Angle Glaucoma or Ocular Hypertension
• Currently on prostaglandin therapy

You may not qualify if…

• Uncontrolled medical conditions
• Subjects who wear contact lenses
• Subjects requiring chronic topical artificial tears, lubricants, and /or - requiring any other chronic topical medications

Where it is running

• Menlo Park — Menlo Park, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.